lobbying_activities: 2976357

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2976357	dd2ef5d3-829f-4f42-a8c0-46958f744a7d	Q1	BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC	292972	BOEHRINGER INGELHEIM USA CORPORATION	2023	first_quarter	ANI	Issues related to Animal Health Issues related to Veterinary Telehealth Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418)	Agriculture, Dept of (USDA),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,SENATE		1420000	0	0	2023-04-20T10:17:38-04:00